엑소좀 (Exosome) 연구 시장조사 보고서

Report Overview

The exosome research market is projected to reach USD 356 million by 2028 from an estimated USD 169 million in 2023, at a CAGR of 16.0% during the forecast period.

엑소좀 연구 시장은 예측 기간 동안 CAGR 16.0%로 성장해 2023년 약 1억 6,900만 달러 규모에서 2028년까지 3억 5,600만 달러에 이를 것으로 예상됩니다.

The growth of this market can be attributed to the increasing incidence of chronic diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions, which has driven the demand for advanced diagnostic and therapeutic solutions. Exosomes, with their potential as biomarkers and therapeutic delivery vehicles, are positioned to address this demand.

“The kits & reagents segment accounted for the largest share by product & services in 2022.”
In 2022, the platform segment accounted for the largest share of product & service in the global exosome research market. The factors like kits and reagents provide researchers with ready-to-use solutions, simplifying the complex processes involved in exosome research is impending growth of the segment. The convenience and user-friendly nature of these kits contribute to their widespread adoption, especially among researchers who may not have extensive expertise in exosome isolation and analysis.

The North America region continued to dominate the exosome research market during the forecast period of 2023-2028.”
North America dominated the global exosome research market in 2022. Government agencies in North America, such as the National Institutes of Health (NIH) in the United States, allocate significant funding to biomedical research. This funding supports a wide range of projects, including those related to exosome research. Government support provides a critical financial boost to researchers and institutions, fostering innovation and advancement in the field. These factors are contributing to the growth of the North American exosome research market.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc. (US)
• Bio-Techne (US)
• System Biosciences, LLC (US)
• QIAGEN (Germany)
• Lonza (Switzerland)
• NX Pharmagen (US)
• NanoSomiX (US)
• Miltenyi Biotech (Germany)
• Norgen Biotek Corp. (Canada)
• AMSBio (UK)
• Aethlon Medical, Inc. (US)
• Anjarium Biosciences AG (UK)
• Ciloa (France)
• InnovaPrep LLC (US)
• Creative Medical Technologies Holdings, Inc. (US)
• ILIAS Biologics, Inc. (South Korea)
• Unchained Labs (US)
• Rion, Inc. (US)
• Cell Guidance System, LLC (UK)
• INOVIQ (Australia)
• Danaher Corporation (US)
• Exopharm (Australia)
• Everzom (France)
• RoosterBio, Inc. (US)
• Creative Biolabs (US)

Research Coverage:
This research report categorizes the exosome research market by product & service (reagents & kits (antibodies, isolation purification, quantitation kits & reagents, and other kits & reagents) instruments, service), by indication (cancer indication (lung cancer, breast cancer, prostate cancer, colorectal cancer, other cancers), neurodegenerative diseases, cardiovascular diseases, infectious diseases, and other indications), by application (biomarkers, vaccine development, tissue regeneration, and other applications), by manufacturing services (stem cell-derived exosome manufacturing services, dendritic cell-derived exosome manufacturing services, and other manufacturing services) by end user (academic & research institutes, pharmaceutical & biotechnological companies, and hospitals & clinical laboratories). The report’s scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the exosome research market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the exosome research market.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall exosome research market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (Increasing investment in pharmaceutical and life sciences research, rising cancer prevalence, increasing interest in exosome-based procedures), restraints (Technical complexity of exosome isolation and technological limitations, regulatory uncertainty in exosome research), opportunities (Rising investments in emerging countries for exosome research, growing interest in exosome-based therapeutics, increasing demand for personalized medicine), and challenges (Lack of gold standard protocols for development & production of exosomes, limited understanding of cargo loading) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products in the exosome research market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the exosome research market
• Competitive Assessment: Thermo Fisher Scientific, Inc. (US), Bio-Techne (US), System Biosciences, LLC (US), QIAGEN (Germany), Lonza (Switzerland), NX Pharmagen (US), NanoSomiX (US), Miltenyi Biotech (Germany), Norgen Biotek Corp. (Canada), AMSBio (UK), Aethlon Medical, Inc. (US), Anjarium Biosciences AG (UK), Ciloa (France), InnovaPrep LLC (US), Creative Medical Technologies Holdings, Inc. (US), ILIAS Biologics, Inc. (South Korea), Unchained Labs (US), Rion, Inc. (US), Cell Guidance System, LLC (UK), INOVIQ (Australia), Danaher Corporation (US), Exopharm (Australia), Everzom (France), RoosterBio, Inc. (US), and Creative Biolabs (US).

Table of Contents

1            INTRODUCTION            32

1.1         STUDY OBJECTIVES      32

1.2         MARKET DEFINITION   32

1.2.1      INCLUSIONS AND EXCLUSIONS 33

1.3         MARKETS COVERED     33

1.3.1      MARKET SCOPE             33

1.3.2      YEARS CONSIDERED     34

1.3.3      CURRENCY CONSIDERED          34

1.4         STAKEHOLDERS            34

1.5         SUMMARY OF CHANGES            35

1.5.1      RECESSION IMPACT      35

2            RESEARCH METHODOLOGY     36

2.1         RESEARCH DATA           36

FIGURE 1           RESEARCH DESIGN       36

2.1.1      SECONDARY DATA       37

2.1.2      PRIMARY DATA 37

FIGURE 2           BREAKDOWN OF PRIMARIES: EXOSOME RESEARCH MARKET              38

2.2         MARKET ESTIMATION METHODOLOGY            38

FIGURE 3           EXOSOME RESEARCH MARKET SIZE ESTIMATION  (SUPPLY-SIDE ANALYSIS), 2022    38

FIGURE 4           MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022             39

2.2.1      INSIGHTS FROM PRIMARY EXPERTS      40

FIGURE 5           MARKET SIZE VALIDATION FROM PRIMARY SOURCES  40

2.3         MARKET GROWTH RATE PROJECTIONS             41

FIGURE 6           EXOSOME RESEARCH MARKET (SUPPLY-SIDE): CAGR PROJECTIONS  42

FIGURE 7           EXOSOME RESEARCH MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS  42

2.3.1      DATA TRIANGULATION             43

FIGURE 8           DATA TRIANGULATION METHODOLOGY         43

2.4         LIMITATIONS   44

2.5         RESEARCH ASSUMPTIONS         44

2.6         RISK ANALYSIS 44

2.7         RECESSION IMPACT      45

TABLE 1             GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)         45

TABLE 2             US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 46

TABLE 3             US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 46

3            EXECUTIVE SUMMARY 47

FIGURE 9           EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2023 VS. 2028 (USD MILLION)     47

FIGURE 10         EXOSOME RESEARCH MARKET, BY INDICATION, 2023 VS. 2028 (USD MILLION) 48

FIGURE 11         EXOSOME RESEARCH MARKET, BY APPLICATION,  2023 VS. 2028 (USD MILLION)     48

FIGURE 12         EXOSOME RESEARCH MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 49

FIGURE 13         EXOSOME RESEARCH MARKET: GEOGRAPHICAL SNAPSHOT              50

4            PREMIUM INSIGHTS      51

4.1         EXOSOME RESEARCH MARKET OVERVIEW        51

FIGURE 14         RISING INVESTMENTS IN PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH    51

4.2         EXOSOME RESEARCH MARKET: BY MANUFACTURING SERVICE 52

FIGURE 15         STEM CELL-DERIVED EXOSOME MANUFACTURING SERVICES TO HOLD LARGEST MARKET SHARE TILL 2028 52

4.3         ASIA PACIFIC: EXOSOME RESEARCH MARKET SHARE,  BY APPLICATION & COUNTRY (2022)          53

FIGURE 16         BIOMARKERS ACCOUNTED FOR LARGEST SHARE OF APPLICATION  SEGMENT IN 2022         53

4.4         EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2023 VS. 2028 (USD MILLION) 54

FIGURE 17         LUNG CANCER SEGMENT CONTINUES TO DOMINATE MARKET IN 2028             54

4.5         EXOSOME RESEARCH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           54

FIGURE 18         NORTH AMERICA AND EUROPE MARKETS TO SHOW HIGHER GROWTH          54

4.6         EXOSOME RESEARCH MARKET SHARE, BY END USER, 2022         55

FIGURE 19         ACADEMIC & RESEARCH INSTITUTES TO DOMINATE MARKET DURING  FORECAST PERIOD   55

5            MARKET OVERVIEW     56

5.1         INTRODUCTION            56

5.2         MARKET DYNAMICS     56

FIGURE 20         EXOSOME RESEARCH MARKET: DRIVERS, RESTRAINTS,  OPPORTUNITIES, AND CHALLENGES    56

TABLE 4             EXOSOME RESEARCH MARKET: IMPACT ANALYSIS        57

5.2.1      DRIVERS            57

5.2.1.1   Increasing investment in pharmaceutical and life sciences research          57

5.2.1.2   Rising cancer prevalence   58

TABLE 5             GLOBAL CANCER INCIDENCE, 2022 VS. 2025      58

5.2.1.3   Increasing interest in exosome-based procedures         59

5.2.2      RESTRAINTS     59

5.2.2.1   Technical complexity of exosome isolation and technological limitations  59

5.2.2.2   Regulatory uncertainty in exosome research  60

5.2.3      OPPORTUNITIES           60

5.2.3.1   Rising investments in emerging countries for exosome research 60

5.2.3.2   Growing interest in exosome-based therapeutics         61

5.2.3.3   Increasing demand for personalized medicine 61

5.2.4      CHALLENGES   62

5.2.4.1   Lack of gold standard protocols for exosome development and production              62

5.2.4.2   Limited understanding of cargo loading         62

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 63

FIGURE 21         REVENUE SHIFT AND NEW POCKETS FOR EXOSOME PROVIDERS       63

5.4         PRICING ANALYSIS        63

TABLE 6             AVERAGE SELLING PRICES OF KEY PLAYERS, BY PRODUCT              64

TABLE 7             REGIONAL VARIATIONS IN PRODUCT COSTS    64

5.5         VALUE CHAIN ANALYSIS            64

FIGURE 22         VALUE CHAIN ANALYSIS OF EXOSOME RESEARCH: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE       64

5.6         SUPPLY CHAIN ANALYSIS          65

FIGURE 23         EXOSOME RESEARCH MARKET: SUPPLY CHAIN ANALYSIS              66

5.7         ECOSYSTEM/MARKET MAP       66

FIGURE 24         EXOSOME RESEARCH MARKET ECOSYSTEM      66

TABLE 8             EXOSOME RESEARCH MARKET: ROLE IN ECOSYSTEM   67

5.8         TECHNOLOGY ANALYSIS           68

TABLE 9             EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS—EXOSOME ISOLATION  68

TABLE 10           EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS—EXOSOME CHARACTERIZATION            69

TABLE 11           EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS—EXOSOME ANALYSIS     69

5.9         PATENT ANALYSIS        70

FIGURE 25         PATENT APPLICATIONS FOR EXOSOME RESEARCH MARKET, JANUARY 2013–OCTOBER 2023  70

TABLE 12           INDICATIVE LIST OF PATENTS IN EXOSOME RESEARCH MARKET            71

5.10       KEY CONFERENCES AND EVENTS, 2024–2025     72

TABLE 13           EXOSOME RESEARCH MARKET: DETAILED LIST OF CONFERENCES AND EVENTS    72

5.11       REGULATORY ANALYSIS            73

5.11.1    NORTH AMERICA          74

5.11.1.1 US         74

5.11.1.2 Canada  74

5.11.2    EUROPE             74

5.11.2.1 Germany             74

5.11.2.2 France   75

5.11.2.3 UK         75

5.11.3    ASIA PACIFIC    75

5.11.3.1 China     75

5.11.3.2 Japan     76

5.11.3.3 India      76

5.11.4    REST OF THE WORLD   76

5.11.4.1 Brazil     76

5.11.4.2 Argentina            76

5.11.4.3 Saudi Arabia        77

5.11.5    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          77

TABLE 14           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         77

TABLE 15           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77

TABLE 16           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         78

TABLE 17           REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         79

5.12       PORTER’S FIVE FORCES ANALYSIS         79

TABLE 18           EXOSOME RESEARCH MARKET: PORTER’S FIVE FORCES ANALYSIS          79

5.12.1    THREAT OF NEW ENTRANTS    80

5.12.2    THREAT OF SUBSTITUTES         80

5.12.3    BARGAINING POWER OF SUPPLIERS     80

5.12.4    BARGAINING POWER OF BUYERS           80

5.12.5    INTENSITY OF COMPETITIVE RIVALRY 81

5.13       KEY STAKEHOLDERS AND BUYING CRITERIA    81

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         81

FIGURE 26         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EXOSOME PRODUCTS & SERVICES         81

5.13.2    BUYING CRITERIA FOR EXOSOME PRODUCTS & SERVICES         82

FIGURE 27         KEY BUYING CRITERIA FOR END USERS              82

6            EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE           84

6.1         INTRODUCTION            85

TABLE 19           EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)     85

6.2         KITS & REAGENTS         85

TABLE 20           EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION,  2021–2028 (USD MILLION)          86

TABLE 21           NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)      86

TABLE 22           EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 86

TABLE 23           ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)      87

TABLE 24           EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          87

6.2.1      ANTIBODIES     87

6.2.1.1   High demand for exosome-based markers for disease detection to propel growth              87

TABLE 25           EXOSOME RESEARCH ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION)     88

TABLE 26          NORTH AMERICA: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)         88

TABLE 27           EUROPE: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 89

TABLE 28           ASIA PACIFIC: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 89

6.2.2      ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS              89

6.2.2.1   Availability of rapid and easy-to-use kits & reagents to ensure sustained demand              89

TABLE 29           EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)          90

TABLE 30           NORTH AMERICA: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    90

TABLE 31           EUROPE: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90

TABLE 32           ASIA PACIFIC: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    91

6.2.3      OTHER KITS & REAGENTS         91

TABLE 33           OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION,  2021–2028 (USD MILLION)     91

TABLE 34           NORTH AMERICA: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)  92

TABLE 35           EUROPE: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)      92

TABLE 36           ASIA PACIFIC: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         92

6.3         INSTRUMENTS 93

6.3.1      DEMAND FOR SCALABLE EXOSOME DEVELOPMENT VIA HIGH-THROUGHPUT SYSTEMS TO DRIVE GROWTH   93

TABLE 37           EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)          93

TABLE 38           NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)      94

TABLE 39           EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 94

TABLE 40           ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)         94

6.4         SERVICES          95

6.4.1      LACK OF IN-HOUSE RESOURCES TO SUPPORT GROWTH OF SERVICES SECTOR             95

TABLE 41           EXOSOME RESEARCH SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)     95

TABLE 42           NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)         95

TABLE 43           EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 96

TABLE 44           ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 96

7            EXOSOME RESEARCH MARKET, BY INDICATION             97

7.1         INTRODUCTION            98

TABLE 45           EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 98

7.2         CANCER             98

TABLE 46           EXOSOME RESEARCH MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION)     99

TABLE 47           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY,  2021–2028 (USD MILLION)      99

TABLE 48           EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY,  2021–2028 (USD MILLION) 99

TABLE 49           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY,  2021–2028 (USD MILLION) 100

TABLE 50           EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION)     100

7.2.1      LUNG CANCER 100

7.2.1.1   Increasing prevalence and advancements in instruments and assays for liquid biopsy to drive market       100

TABLE 51           EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY REGION,  2021–2028 (USD MILLION)     101

TABLE 52           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2021–2028 (USD MILLION)         101

TABLE 53           EUROPE: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY,  2021–2028 (USD MILLION)         102

TABLE 54           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY,  2021–2028 (USD MILLION)      102

7.2.2      BREAST CANCER            102

7.2.2.1   High prevalence and increasing awareness to drive market         102

TABLE 55           EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY REGION,  2021–2028 (USD MILLION)     103

TABLE 56           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2021–2028 (USD MILLION)         103

TABLE 57           EUROPE: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY,  2021–2028 (USD MILLION)         104

TABLE 58           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY,  2021–2028 (USD MILLION)      104

7.2.3      PROSTATE CANCER      104

7.2.3.1   Effectiveness of liquid biopsy in detecting prostate cancer before surgery to support market growth       104

TABLE 59           EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY REGION,  2021–2028 (USD MILLION)     105

TABLE 60           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2021–2028 (USD MILLION)   105

TABLE 61           EUROPE: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY,  2021–2028 (USD MILLION)      106

TABLE 62           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2021–2028 (USD MILLION)         106

7.2.4      COLORECTAL CANCER 106

7.2.4.1   Increasing exosome-based research and projects to propel market            106

TABLE 63           EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY REGION,  2021–2028 (USD MILLION)     107

TABLE 64           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER,  BY COUNTRY, 2021–2028 (USD MILLION)        107

TABLE 65           EUROPE: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY,  2021–2028 (USD MILLION)      107

TABLE 66           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2021–2028 (USD MILLION)           108

7.2.5      OTHER CANCERS           108

TABLE 67           EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY REGION,  2021–2028 (USD MILLION)     108

TABLE 68           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2021–2028 (USD MILLION)       109

TABLE 69          EUROPE: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY,  2021–2028 (USD MILLION)         109

TABLE 70           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY,  2021–2028 (USD MILLION)     109

7.3         NEURODEGENERATIVE DISEASES         110

7.3.1      POTENTIAL APPLICATIONS OF SALIVARY EXOSOMAL CARGO CONTENT IN TREATMENT TO DRIVE MARKET 110

TABLE 71           EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION,  2021–2028 (USD MILLION)        110

TABLE 72           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)              111

TABLE 73           EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES,  BY COUNTRY, 2021–2028 (USD MILLION)              111

TABLE 74           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES,  BY COUNTRY, 2021–2028 (USD MILLION)              111

7.4         CARDIOVASCULAR DISEASES   112

7.4.1      EXPANDING RESEARCH ON CVD APPLICATIONS TO PROPEL SEGMENT GROWTH     112

TABLE 75           EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)           112

TABLE 76           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES,  BY COUNTRY, 2021–2028 (USD MILLION)              112

TABLE 77           EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 113

TABLE 78           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES,  BY COUNTRY, 2021–2028 (USD MILLION)              113

7.5         INFECTIOUS DISEASES 113

7.5.1      POTENTIAL FOR DEEPER UNDERSTANDING OF INFECTIOUS DISEASE THERAPEUTICS TO DRIVE MARKET      113

TABLE 79           EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION,  2021–2028 (USD MILLION)     114

TABLE 80           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES,  BY COUNTRY, 2021–2028 (USD MILLION)         114

TABLE 81           EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)       115

TABLE 82           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)       115

7.6         OTHER INDICATIONS   115

TABLE 83           EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION,  2021–2028 (USD MILLION)     116

TABLE 84           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)             116

TABLE 85           EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)           116

TABLE 86           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)             117

8            EXOSOME RESEARCH MARKET, BY APPLICATION          118

8.1         INTRODUCTION            119

TABLE 87           EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119

8.2         BIOMARKERS    119

8.2.1      BIOMARKERS TO HOLD LARGEST SHARE OF APPLICATIONS MARKET              119

TABLE 88           EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION,  2021–2028 (USD MILLION)          120

TABLE 89           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2021–2028 (USD MILLION) 120

TABLE 90           EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY,  2021–2028 (USD MILLION) 120

TABLE 91           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2021–2028 (USD MILLION) 121

8.3         VACCINE DEVELOPMENT          121

8.3.1      GROWING INTEREST IN EXOSOMES IN INFECTIOUS DISEASE THERAPEUTICS TO DRIVE MARKET      121

TABLE 92           EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION,  2021–2028 (USD MILLION)             121

TABLE 93           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT,  BY COUNTRY, 2021–2028 (USD MILLION)    122

TABLE 94           EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)          122

TABLE 95           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)          122

8.4         TISSUE REGENERATION            123

8.4.1      MINIMAL SIDE EFFECTS AND HIGH EFFICACY OF EXOSOMES TO SUPPORT ADOPTION   123

TABLE 96           EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION,  2021–2028 (USD MILLION)             123

TABLE 97           NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION,  BY COUNTRY, 2021–2028 (USD MILLION)      123

TABLE 98           EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2021–2028 (USD MILLION)         124

TABLE 99           ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2021–2028 (USD MILLION)         124

8.5         OTHER APPLICATIONS 124

TABLE 100         EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)     125

TABLE 101         NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)        125

TABLE 102         EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)        125

TABLE 103         ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)           126

9            EXOSOME RESEARCH MARKET, BY END USER   127

9.1         INTRODUCTION            128

TABLE 104         EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION)          128

9.2         ACADEMIC & RESEARCH INSTITUTES   128

9.2.1      ACADEMIC & RESEARCH INSTITUTES TO HOLD LARGEST SHARE OF END-USER MARKET      128

TABLE 105         EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)      129

TABLE 106         NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)              129

TABLE 107         EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2021–2028 (USD MILLION)        129

TABLE 108         ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)       130

9.3         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   130

9.3.1      SIGNIFICANT DEVELOPMENTS IN NANOMEDICINE TO DRIVE MARKET              130

TABLE 109         EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 130

TABLE 110         NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 131

TABLE 111         EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 131

TABLE 112         ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 131

9.4         HOSPITALS & CLINICAL TESTING LABORATORIES         132

9.4.1      RISING ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO DRIVE MARKET             132

TABLE 113         EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES,  BY REGION, 2021–2028 (USD MILLION)        132

TABLE 114         NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 132

TABLE 115         EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)              133

TABLE 116         ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)          133

10          EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE 134

10.1       INTRODUCTION            135

TABLE 117        EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE,  2021–2028 (USD MILLION)          135

10.2       STEM CELL-DERIVED EXOSOME MANUFACTURING      135

10.2.1    RISING DEMAND FOR MSC EXOSOMES IN THERAPEUTICS TO DRIVE MARKET            135

10.3       DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING         136

10.3.1    SIGNIFICANT DEVELOPMENTS IN DC-EXOSOME IMMUNOTHERAPY TO PROPEL GROWTH  136

10.4       OTHER EXOSOME MANUFACTURING SERVICES             136

11          EXOSOME RESEARCH MARKET, BY REGION       137

11.1       INTRODUCTION            138

TABLE 118         EXOSOME RESEARCH MARKET, KEYWORD ANALYSIS (2001-2022)    138

TABLE 119         EXOSOME RESEARCH MARKET, BY REGION, 2021–2028 (USD MILLION)          138

11.2       NORTH AMERICA          139

FIGURE 28         NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT              139

TABLE 120         NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 140

TABLE 121         NORTH AMERICA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         140

TABLE 122         NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION) 140

TABLE 123         NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION,  2021–2028 (USD MILLION)           141

TABLE 124         NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION) 141

TABLE 125         NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        142

TABLE 126         NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER,  2021–2028 (USD MILLION)          142

11.2.1    US         142

11.2.1.1 HIGH BURDEN OF CANCER AND FAVORABLE PUBLIC & PRIVATE FUNDING FOR RESEARCH TO DRIVE MARKET  142

TABLE 127         US: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)          143

TABLE 128         US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)          143

TABLE 129         US: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 144

TABLE 130         US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION)          144

TABLE 131         US: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     144

TABLE 132         US: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 145

11.2.2    CANADA            145

11.2.2.1 INCREASING FUNDING FOR GENOME-BASED MEDICAL TREATMENTS TO SUPPORT MARKET GROWTH           145

TABLE 133         CANADA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    146

TABLE 134         CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)          146

TABLE 135         CANADA: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION)          146

TABLE 136         CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION)          147

TABLE 137         CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          147

TABLE 138         CANADA: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION)     148

11.2.3    NORTH AMERICA: RECESSION IMPACT 148

11.3       EUROPE             148

FIGURE 29         EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT     149

TABLE 139         EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     150

TABLE 140         EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    150

TABLE 141         EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)          150

TABLE 142         EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION)          151

TABLE 143         EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION)          151

TABLE 144         EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          152

TABLE 145         EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION)     152

11.3.1    GERMANY         152

11.3.1.1 Germany to dominate European market        152

TABLE 146         GERMANY: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    153

TABLE 147         GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)    153

TABLE 148         GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION)          154

TABLE 149         GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION)          154

TABLE 150         GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          155

TABLE 151         GERMANY: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION)     155

11.3.2    UK         155

11.3.2.1 Growing life sciences industry to drive market             155

TABLE 152         UK: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)          156

TABLE 153        UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)          156

TABLE 154         UK: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 157

TABLE 155         UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION)          157

TABLE 156         UK: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     157

TABLE 157         UK: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 158

11.3.3    FRANCE             158

11.3.3.1 Strong collaborative network between biotechnology entities and research institutes to support growth             158

TABLE 158         FRANCE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    159

TABLE 159         FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)          159

TABLE 160         FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION)          159

TABLE 161         FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION)          160

TABLE 162         FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          160

TABLE 163         FRANCE: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION)     161

11.3.4    REST OF EUROPE           161

TABLE 164         REST OF EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         162

TABLE 165         REST OF EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION) 162

TABLE 166         REST OF EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION,  2021–2028 (USD MILLION)           163

TABLE 167        REST OF EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION)    163

TABLE 168         REST OF EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        164

TABLE 169         REST OF EUROPE: EXOSOME RESEARCH MARKET, BY END USER,  2021–2028 (USD MILLION)          164

11.3.5    EUROPE: RECESSION IMPACT   165

11.4       ASIA PACIFIC    165

TABLE 170         ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          165

TABLE 171         ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    166

TABLE 172         ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION) 166

TABLE 173         ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION,  2021–2028 (USD MILLION)          167

TABLE 174         ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION)          167

TABLE 175         ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        168

TABLE 176         ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION)          168

11.4.1    CHINA  168

11.4.1.1 China to hold largest share in APAC market  168

TABLE 177         CHINA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    169

TABLE 178         CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)          169

TABLE 179         CHINA: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION)     170

TABLE 180         CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION)          170

TABLE 181         CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          171

TABLE 182         CHINA: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION)     171

11.4.2    JAPAN  171

11.4.2.1 High cancer prevalence and increasing healthcare expenditure to drive market              171

TABLE 183         TOTAL NUMBER OF CLINICAL TRIALS IN JAPAN, BY THERAPEUTIC AREA, 2020 VS. 2022        172

TABLE 184         JAPAN: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    172

TABLE 185         JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)          172

TABLE 186         JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION)     173

TABLE 187         JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION)          173

TABLE 188         JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     173

TABLE 189         JAPAN: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION)     174

11.4.3    REST OF ASIA PACIFIC  174

TABLE 190         REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         175

TABLE 191         REST OF ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)           175

TABLE 192         REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION,  2021–2028 (USD MILLION)           176

TABLE 193         REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION) 176

TABLE 194         REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        177

TABLE 195         REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER,  2021–2028 (USD MILLION)          177

11.4.4    ASIA PACIFIC: RECESSION IMPACT        177

11.5       REST OF THE WORLD   178

TABLE 196         REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         178

TABLE 197         REST OF THE WORLD: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE,  2021–2028 (USD MILLION) 179

TABLE 198         REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY INDICATION,  2021–2028 (USD MILLION)           179

TABLE 199         REST OF THE WORLD: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE,  2021–2028 (USD MILLION) 180

TABLE 200         REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        180

TABLE 201         REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY END USER,  2021–2028 (USD MILLION)          181

11.5.1    REST OF THE WORLD: RECESSION IMPACT       181

12          COMPETITIVE LANDSCAPE       182

12.1       OVERVIEW        182

12.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          182

FIGURE 30         OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020- 2023      183

12.3       REVENUE ANALYSIS      184

FIGURE 31         REVENUE ANALYSIS OF TOP FIVE MARKET PLAYERS (2018–2022)    184

12.4       MARKET SHARE ANALYSIS         184

TABLE 202         EXOSOME RESEARCH MARKET: DEGREE OF COMPETITION              185

12.5       COMPANY EVALUATION MATRIX          186

12.5.1    STARS  186

12.5.2    EMERGING LEADERS    187

12.5.3    PERVASIVE       187

12.5.4    EMERGING COMPANIES             187

FIGURE 33         EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX, 2022    187

12.5.5    COMPANY FOOTPRINT 188

TABLE 203         COMPANY FOOTPRINT (25 COMPANIES)           188

TABLE 204         PRODUCT & SERVICE FOOTPRINT (25 COMPANIES)      189

TABLE 205         GEOGRAPHIC FOOTPRINT (25 COMPANIES)     190

12.6       START-UP/SME EVALUATION MATRIX 191

12.6.1    PROGRESSIVE COMPANIES       191

12.6.2    STARTING BLOCKS       191

12.6.3    RESPONSIVE COMPANIES          191

12.6.4    DYNAMIC COMPANIES 191

FIGURE 34         EXOSOME RESEARCH MARKET: START-UP/SME EVALUATION MATRIX, 2022    192

12.6.5    COMPETITIVE BENCHMARKING            193

TABLE 206         EXOSOME RESEARCH MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS           193

TABLE 207         EXOSOME RESEARCH MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES] 194

12.7       COMPETITIVE SCENARIO          195

13          COMPANY PROFILES    196

13.1       KEY PLAYERS   196

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

13.1.1    THERMO FISHER SCIENTIFIC INC.          196

TABLE 208         THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW              196

FIGURE 35         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)   197

13.1.2    QIAGEN             200

TABLE 209         QIAGEN: COMPANY OVERVIEW 200

FIGURE 36         QIAGEN: COMPANY SNAPSHOT (2022)  201

13.1.3    LONZA 203

TABLE 210         LONZA: COMPANY OVERVIEW 203

FIGURE 37         LONZA: COMPANY SNAPSHOT (2022)    204

13.1.4    SYSTEM BIOSCIENCES, LLC       206

TABLE 211         SYSTEM BIOSCIENCES, LLC: COMPANY OVERVIEW        206

13.1.5    BIO-TECHNE    208

TABLE 212         BIO-TECHNE: COMPANY OVERVIEW     208

FIGURE 38         BIO-TECHNE: COMPANY SNAPSHOT (2022)       209

13.1.6    DANAHER CORPORATION         212

TABLE 213         DANAHER CORPORATION: COMPANY OVERVIEW         212

FIGURE 39         DANAHER CORPORATION: COMPANY SNAPSHOT (2022)              213

13.1.7    AMSBIO             215

TABLE 214         AMSBIO: COMPANY OVERVIEW 215

13.1.8    ROOSTERBIO, INC.        217

TABLE 215         ROOSTERBIO, INC.: COMPANY OVERVIEW         217

13.1.9    MILTENYI BIOTEC         219

TABLE 216         MILTENYI BIOTEC: COMPANY OVERVIEW         219

13.1.10  NORGEN BIOTEK CORP.             220

TABLE 217         NORGEN BIOTEK CORP.: COMPANY OVERVIEW             220

13.2       OTHER PLAYERS           222

13.2.1    AETHLON MEDICAL, INC.          222

13.2.2    ANJARIUM BIOSCIENCES AG     222

13.2.3    CILOA  223

13.2.4    INNOVAPREP, LLC        223

13.2.5    CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC,    224

13.2.6    ILIAS BIOLOGICS INC.   224

13.2.7    UNCHAINED LABS         225

13.2.8    RION INC.          225

13.2.9    CELL GUIDANCE SYSTEMS LLC 226

13.2.10  INOVIQ 226

13.2.11  NX PHARMAGEN            227

13.2.12  EXOPHARM      227

13.2.13  EVERZOM         228

13.2.14  NANOSOMIX     229

13.2.15  CREATIVE BIOLABS       229

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14          APPENDIX         231

14.1       DISCUSSION GUIDE      231

14.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             235

14.3       CUSTOMIZATION OPTIONS      237

14.4       RELATED REPORTS       237

14.5       AUTHOR DETAILS         238